Japanese R&D funding increased last fiscal year for the first time in four years. The country’s total R&D spending rose 1.6% in fiscal 2012 (ending March 31, 2012) to ¥17,379 billion ($217.2 billion = ¥80 = $1), according to the annual R&D survey of the Statistics Bureau of Japan’s Ministry of Internal Affairs and Communications. […]
US equity prices flourished to start the year as fears over the fiscal cliff diminished. The US Congress agreed on income tax rates and temporarily resolved the debt ceiling issue. In addition, economic figures continued to advance and corporate earnings were mostly ahead of expectations. Despite a negative 0.1% fourth-quarter US GDP due to lower […]
Newly elected President Enrique Peña Nieto plans to create a scientific road map for the nation. The road map will aim to increase funding for science to a minimum of 1% of GDP, compared with the current figure of 0.4%. The road map will also seek to create a closer collaboration between academic institutions and […]
The convergence of highly capable instruments and the need for their performance in many applications is helping the market for TOF GC/MS (GC-TOF) to finally begin taking off. Despite a strong array of products from smaller MS competitors, the technology has now been validated in the eyes of many end-users thanks to the entrance of […]
Illumina has recently been at the center of acquisition-related activity and announcements. The company purchased two companies, Verinata Health and Moleculo, in January (see IBO 1/15/13). It also ended its pursuit of another. On January 8, the company announced it had withdrawn its offer to acquire sequencing service provider Complete Genomics (see IBO 11/30/12). The […]
Late last year, Biocartis began shipping its first commercial product. The biomarker detection platform utilizes the company’s Dynamic Multi-Analyte Technology (DMAT), allowing users to measure 2,000 analytes simultaneously. Most technologies cannot measure nucleic acids and proteins simultaneously, so different technologies or systems are required, said Allison Ballmer, global marketing manager for the DMAT platform. The […]
Company Announcements Protea named new distributors: Yair Technologies for Israel, BioAnalytic for Poland, Irida Iberica for Spain and Portugal, and IDL Teknolojik for Turkey. Bruker announced in October 2012 a collaboration with Nextval for high-throughput screening of drugs and their metabolites using its ultrafleXtreme MALDI-TOF/TOF. Thermo Fisher Scientific announced a collaboration with Immundiagnostik to develop […]
Company Announcements Ingenuity Systems announced in November 2012 a long-term collaboration with LabCorp to license and deploy its clinical content and applications to rapidly review and annotate clinically relevant sequence variations. Cartagenia integrated Interactive Biosoftware’s Alamut gene visualization software into its BENCHlab platform, a web-based software and database platform that interprets genomic variation in routine […]
Company Announcements As the result of an expanded licensing and commercialization relationship with Lankenau Institute for Medical Research, Rockland Immunochemicals now markets CellCountEZ, OxPhos, RadDose and Intracelluar ThioEZ assays and additional products. StemCells partnered with R Biomedical to develop and commercialize a range of cell lines and reagents to facilitate human induced pluripotent stem (iPS) […]
Company Announcements Horizon Technology appointed Board member Dr. Peter Brown as CEO in September 2012. Previously, he served as general manager of VG Elemental. Claremont BioSolutions announced in October 2012 a strategic partnership and technology development agreement with In-Q-Tel for its Prep-on-a-Chip. Pressure BioSciences signed a supplier agreement with Cole-Parmer for its PBI Shredder SG3 […]
Pay Invoice
Latest Blogs
-
LAUDA: Temperature Control Innovation
December 10, 2024 4:11 pm
-
Perseverance Forecasted for the Pharmaceutical Market for Analytical and Scientific Instrumentation
October 24, 2024 5:17 pm
-
M&A Activity in the Analytical Instrumentation and Lab Tools Market. 2021-2023
September 30, 2024 1:32 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
